Skip to main content
Clinical Trials/CTRI/2022/11/047213
CTRI/2022/11/047213Not yet recruitingPhase 2/3

Clinical Study To Evaluate The Effect Of Udavarta Roga Nashaka Arka In Udavartini Yoni Vyapath (Primary Dysmenorrhoea)

Dr ASWINI S1 site in 1 country30 target enrollmentStarted: November 15, 2022Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To see the reduction in the insensitive of pain

Study Overview

Brief Summary

Udavarthini yoni vyapath is one among the vataja yoni vyapath.Normal menstruation is thefunction of Apana vata therefore painful menstruation is considered as Apana vatadushti. As movement of vata is in reverse direction of the course of uterine contraction, the womanbecomes afflicted with pain and discharges the menstrual blood with great difficulty that is tending in a reverse direction. Apana vata is having the function of nishkramana of artava and its vitiation will lead to Udavartini yoni vyapath.Nidana, Samprapthi and Rupa of Udavartini yoni vyapat can be well explained with the etiopathogenesis and clinical features of Primary dysmenorrhoea.Primary dysmenorrhea is painful menstruation without any underlying pelvic pathology associated with nausea, vomiting, headache, fatigue. Previously many studies have been conducted for the same condition on Shodhana karmas mainly Vasthi and other oral medications. Arka kalpana is avery unique form of medicine by its palatability, increased potency and reduced dose. So as we are searching for more convenient forms of medication, Udavarta roga nasaka arka mentioned in Arka prakasha is selected for present study. The drugs included are Trikatu, Pippali mula, Trivrut, Danti and Chitraka with Guda as Anupana, most of the drugs are Vatanulomana and Sulahara in action.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Not Applicable

Eligibility Criteria

Ages
16.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1.Patients fulfilling the diagnostic criteria.
  • 2.Age between 16-35 years 3.Painful menstruation for at least previous 2 consecutive cycles, 4.Patients with regular menstrual cycles.

Exclusion Criteria

  • 1.Cases of Secondary dysmenorrhoea with underlying pelvic pathology diagnosed by USG like Pelvic inflammatory disease, fibroids, endometriosis.
  • 2.Patient with intrauterine contraceptive devices 3.Patient’s on hormonal therapy 4.Patient with gastritis 5.Known case of HIV, HBsAg, VDRL.

Outcomes

Primary Outcomes

To see the reduction in the insensitive of pain

Time Frame: On completion of 2nd cycles and 3rd cycle

and associated symptoms

Time Frame: On completion of 2nd cycles and 3rd cycle

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr ASWINI S
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials